Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
Journal of Cancer Research and Therapeutics, a publication of Association of Radiation Oncologists of India (AROI), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published. The journalís full text is available online at http://www.cancerjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
CURRENT COVER
EDITORIAL BOARD

Editor in Chief
Dr. Kishore Singh

Executive Editor
Dr. Arun Rathi, New Delhi, India

Associate Editor
Dr. D N Sharma , New Delhi, India

View All Members

JCRT STATISTICS
  • 3,612 Total articles
  • 3,611 Full text articles
  • 957 Manuscripts submitted in '20
  • 176,214 Articles downloaded in 'June 2020

Special Issue

September 2013 Volume 9 | Issue 5 (Supplement)

Special Issue

November 2013 Volume 9 | Issue 7 (Supplement)

CURRENT ISSUE
2020| Vol 16| Issue 2

Editorial

Management of pulmonary multifocal ground-glass nodules: How many options do we have?

In 1996, the concept of pulmonary ground-glass nodule (GGN) or ground-glass opacity (GGO) nodule wasfirst proposed by the Fleischner Society.[1] Based on whether GGN contains the consolidation, it c...


Original Article

Experimental study on radiation damage of125I seeds implanted in canine gastric wall tissue

Objective: The objective of the study was to investigate the radiation damage to125 I seeds implanted in canine gastric wall tissue. Materials and Methods: Eight beagles we...


Original Article

Matrine inhibits proliferation and migration of HepG2 cells by downregulating ERK1/2 signaling pathways

Objective: To research the effect of matrine on the proliferation and migration of HepG2 cells through extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway. Methods: H...


Original Article

Berberine enhances the radiosensitivity of osteosarcoma by targeting Rad51 and epithelial–mesenchymal transition

Objective: Osteosarcoma is a malignant bone tumor and is generally treated with radiotherapy combined with radiosensitizers. The aim of the present study was to investigate the radiosensitiza...


View All Articles